Legacy continuation of the KU CMLD Mission
Legacy continuation of the KU CMLD Mission
批准号:
8753214
负责人:
THOMAS EDWARD PRISINZANO
金额:
$54.06万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-08-01 至 2017-07-31
关键词:
AcuteAddressAwardBackBiologicalBiological AssayBiologyBiomedical ResearchChargeChemicalsClientClinical TrialsCollectionCommunitiesDevelopmentElementsEnsureEvaluationFundingFunding MechanismsFunding OpportunitiesFutureGoalsKansasLibrariesLibrary Collection DevelopmentLiquid ChromatographyMaintenanceMethodologyMethodsMetricMissionModelingMolecular BankNIH Program AnnouncementsNational Institute of General Medical SciencesPharmaceutical ChemistryPowder dose formPreparationProcessPublic SectorPublicationsPublishingQuality ControlRecoveryResearchResearch PersonnelResearch Project GrantsResourcesSamplingScientistStagingStructureTestingUnited States National Institutes of HealthUniversitiesValidationanalogbasecostdrug discoveryhigh throughput screeninginterestmembermilligramnoveloperationoutreachprogramspublic health relevancerepositoryscreeningsmall moleculesmall molecule libraries
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): To provide academic researchers with high-quality compound collections for biological screening, the National Institute of General Medical Sciences established the Chemical Methodologies and Library Development (CMLD) Network and charged it with developing new ways of creating libraries and providing them to the SMR. The CMLD network was maintained under a R41 funding mechanism and has been discontinued, making it eligible for consideration as a legacy resource under the present program announcement. As part of the CMLD network, the University of Kansas CMLD center was responsible for developing numerous chemical methods and for providing >7000 compounds to the SMR. Most excitingly, numerous KU CMLD center compounds have been identified as hits in diverse screens, with a few progressing to full-blown development efforts currently underway. The NIH plans to maintain the SMR for the foreseeable future, with new screens being enabled by currently active, project-specific R01 awards (PAR-12-058), meaning that new hits will continue to be identified. However, the ability of researchers to have continued
access to non-commercial compounds, which constitute a valuable and unique asset of the repository, is threatened by diminishing supplies of these compounds, many of which have been depleted. This threat is particularly acute with respect to pure samples (generally powders) that are essential for validation efforts following the initial screen. We propose to address these concerns through the present program. Our near-term goal is to supply scientists who have uncovered screening hits in the SMR with structurally validated quantitatively quality-controlled samples of the hit of interest as well as chemically similar analogs for validation efforts. This wll require a sustained effort in scientific outreach to maximize the potential client base for these activities as well as technical maintenance of our synthetic and compound purification/management capabilities Our long-term goal is to transform our library synthesis and hit validation activities into a sustainable effort that will eventually be supported by cost recovry from project-specific research grants and charge-backs to clients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of Agents for Synthetic Opioid Overdose
-
批准号:10275603
-
项目类别:
-
资助金额:$45.9万
-
财政年份:2021
-
负责人:THOMAS EDWARD PRISINZANO
-
依托单位:
Development of Agents for Synthetic Opioid Overdose
-
批准号:10672919
-
项目类别:
-
资助金额:$44.42万
-
财政年份:2021
-
负责人:THOMAS EDWARD PRISINZANO
-
依托单位:
Development of Agents for Synthetic Opioid Overdose
-
批准号:10470923
-
项目类别:
-
资助金额:$45.01万
-
财政年份:2021
-
负责人:THOMAS EDWARD PRISINZANO
-
依托单位:
Chemical Biology of Infectious Disease
-
批准号:9274106
-
项目类别:
-
资助金额:$226.53万
-
财政年份:2016
-
负责人:THOMAS EDWARD PRISINZANO
-
依托单位:
Alteration and Renovation
-
批准号:8812380
-
项目类别:
-
资助金额:$9.28万
-
财政年份:2016
-
负责人:THOMAS EDWARD PRISINZANO
-
依托单位:
Investigation of Neoclerodanes as Novel Opioid Ligands
-
批准号:9030515
-
项目类别:
-
资助金额:$48.75万
-
财政年份:2016
-
负责人:THOMAS EDWARD PRISINZANO
-
依托单位:
Administrative Core
-
批准号:8812373
-
项目类别:
-
资助金额:$98.92万
-
财政年份:2016
-
负责人:THOMAS EDWARD PRISINZANO
-
依托单位:
Chemical Biology of Infectious Disease
-
批准号:8812366
-
项目类别:
-
资助金额:$236.42万
-
财政年份:2016
-
负责人:THOMAS EDWARD PRISINZANO
-
依托单位:
Investigation of Neoclerodanes as Novel Opioid Ligands
-
批准号:9266380
-
项目类别:
-
资助金额:$43.69万
-
财政年份:2016
-
负责人:THOMAS EDWARD PRISINZANO
-
依托单位:
Core C: Computational Chemical Biology
-
批准号:8812375
-
项目类别:
-
资助金额:$22.27万
-
财政年份:2016
-
负责人:THOMAS EDWARD PRISINZANO
-
依托单位:
Investigation of Neoclerodanes as Novel Opioid Ligands
-
批准号:7033693
-
项目类别:
-
资助金额:$34.25万
-
财政年份:2005
-
负责人:THOMAS EDWARD PRISINZANO
-
依托单位:
Investigation of Neoclerodanes as Novel Opioid Ligands
-
批准号:8523815
-
项目类别:
-
资助金额:$32.8万
-
财政年份:2005
-
负责人:THOMAS EDWARD PRISINZANO
-
依托单位:
Investigation of Neoclerodanes as Novel Opioid Ligands
-
批准号:8306178
-
项目类别:
-
资助金额:$34.21万
-
财政年份:2005
-
负责人:THOMAS EDWARD PRISINZANO
-
依托单位:
Investigation of Neoclerodanes as Novel Opioid Ligands
-
批准号:8702125
-
项目类别:
-
资助金额:$34.13万
-
财政年份:2005
-
负责人:THOMAS EDWARD PRISINZANO
-
依托单位:
Investigation of Neoclerodanes as Novel Opioid Ligands
-
批准号:8035337
-
项目类别:
-
资助金额:$34.24万
-
财政年份:2005
-
负责人:THOMAS EDWARD PRISINZANO
-
依托单位:
Investigation of Neoclerodanes as Novel Opioid Ligands
-
批准号:8472068
-
项目类别:
-
资助金额:$1.73万
-
财政年份:2005
-
负责人:THOMAS EDWARD PRISINZANO
-
依托单位:
Investigation of Neoclerodanes as Novel Opioid Ligands
-
批准号:7424261
-
项目类别:
-
资助金额:$0.91万
-
财政年份:2005
-
负责人:THOMAS EDWARD PRISINZANO
-
依托单位:
Investigation of Neoclerodanes as Novel Opioid Ligands
-
批准号:7493038
-
项目类别:
-
资助金额:$31.78万
-
财政年份:2005
-
负责人:THOMAS EDWARD PRISINZANO
-
依托单位:
Investigation of Neoclerodanes as Novel Opioid Ligands
-
批准号:7266507
-
项目类别:
-
资助金额:$3.74万
-
财政年份:2005
-
负责人:THOMAS EDWARD PRISINZANO
-
依托单位:
Investigation of Neoclerodanes as Novel Opioid Ligands
-
批准号:7127177
-
项目类别:
-
资助金额:$32.29万
-
财政年份:2005
-
负责人:THOMAS EDWARD PRISINZANO
-
依托单位:
海外基金